个人中心 - 老虎社区

Rosechin

IP属地：未知

帖子 · 6帖子 · 6
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- RosechinRosechin
  ·2021-11-26
  Potential growth next year. I invest u
  非常抱歉，此主贴已删除
  791 1
  10
  分享
  举报
- RosechinRosechin
  ·2021-11-23
  thanks you for your sharing
  @我的投资笔记：
  分歧再现：一场人类的内卷，元宇宙可能毁灭我们，风险【第三期 Clip 3/5】
  分歧再现：一场人类的内卷，元宇宙可能毁灭我们，风险【第三期 Clip 3/5】
  835 评论
  点赞
  分享
  举报
- RosechinRosechin
  ·2021-11-20
  Potential growth in us and China market
  非常抱歉，此主贴已删除
  1,023 评论
  点赞
  分享
  举报
- RosechinRosechin
  ·2021-11-19
  Price is attractive now, time to invest for long term growth profits
  非常抱歉，此主贴已删除
  1,858 1
  4
  分享
  举报
- RosechinRosechin
  ·2021-11-19
  Potential
  Pfizer and BioNTech SE stocks climbed about 2% in premarket trading
  Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S
  Pfizer and BioNTech SE stocks climbed about 2% in premarket trading
  1,231 3
  8
  分享
  举报
- RosechinRosechin
  ·2021-11-17
  Good to invest this sharr
  Online Gaming Business Drives Sohu's 37% Revenue Growth In Q3
  
  Online Gaming Business Drives Sohu's 37% Revenue Growth In Q3
  1,065 评论
  点赞
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4097912578278380","uuid":"4097912578278380","gmtCreate":1635413468377,"gmtModify":1636755272247,"name":"Rosechin","pinyin":"rosechin","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/b609bc0ae15909da0a6fbf0d048f7ebd","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":44,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.17","exceedPercentage":"93.31%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":877964719,"gmtCreate":1637879698497,"gmtModify":1637879698497,"author":{"id":"4097912578278380","authorId":"4097912578278380","name":"Rosechin","avatar":"https://static.tigerbbs.com/b609bc0ae15909da0a6fbf0d048f7ebd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097912578278380","authorIdStr":"4097912578278380"},"themes":[],"htmlText":"Potential growth next year. I invest u","listText":"Potential growth next year. I invest u","text":"Potential growth next year. I invest u","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877964719","repostId":"2186916023","repostType":4,"isVote":1,"tweetType":1,"viewCount":791,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875151836,"gmtCreate":1637627204225,"gmtModify":1637627204225,"author":{"id":"4097912578278380","authorId":"4097912578278380","name":"Rosechin","avatar":"https://static.tigerbbs.com/b609bc0ae15909da0a6fbf0d048f7ebd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097912578278380","authorIdStr":"4097912578278380"},"themes":[],"htmlText":"thanks you for your sharing","listText":"thanks you for your sharing","text":"thanks you for your sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875151836","repostId":"842221902","repostType":1,"repost":{"id":842221902,"gmtCreate":1636184623202,"gmtModify":1636185728893,"author":{"id":"9000000000000115","authorId":"9000000000000115","name":"我的投资笔记","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000115","authorIdStr":"9000000000000115"},"themes":[],"title":"","htmlText":"\n \n \n  分歧再现：一场人类的内卷，元宇宙可能毁灭我们，风险【第三期 Clip 3/5】\n \n","listText":"分歧再现：一场人类的内卷，元宇宙可能毁灭我们，风险【第三期 Clip 3/5】","text":"分歧再现：一场人类的内卷，元宇宙可能毁灭我们，风险【第三期 Clip 3/5】","images":[{"img":"https://static.tigerbbs.com/729c5b00e67961d971189bb5e6e4223d","width":"0","height":"0"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842221902","isVote":1,"tweetType":2,"object":{"id":"1dce0c352b1b44c38cee1a5665970d8e","tweetId":"842221902","title":"🟩【200万股票实盘】CRSR要开始上涨","videoUrl":"http://v.tigerbbs.com/1636184620301ede623db534dbf9ee783e2a02a5520a8.mp4","poster":"https://static.tigerbbs.com/729c5b00e67961d971189bb5e6e4223d","shareLink":"http://v.tigerbbs.com/1636184620301ede623db534dbf9ee783e2a02a5520a8.mp4"},"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":835,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876790918,"gmtCreate":1637360074724,"gmtModify":1637360074807,"author":{"id":"4097912578278380","authorId":"4097912578278380","name":"Rosechin","avatar":"https://static.tigerbbs.com/b609bc0ae15909da0a6fbf0d048f7ebd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097912578278380","authorIdStr":"4097912578278380"},"themes":[],"htmlText":"Potential growth in us and China market","listText":"Potential growth in us and China market","text":"Potential growth in us and China market","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876790918","repostId":"2170614570","repostType":2,"isVote":1,"tweetType":1,"viewCount":1023,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876597757,"gmtCreate":1637329796423,"gmtModify":1637329804761,"author":{"id":"4097912578278380","authorId":"4097912578278380","name":"Rosechin","avatar":"https://static.tigerbbs.com/b609bc0ae15909da0a6fbf0d048f7ebd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097912578278380","authorIdStr":"4097912578278380"},"themes":[],"htmlText":"Price is attractive now, time to invest for long term growth profits&nbsp;","listText":"Price is attractive now, time to invest for long term growth profits&nbsp;","text":"Price is attractive now, time to invest for long term growth profits","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876597757","repostId":"2184899191","repostType":2,"isVote":1,"tweetType":1,"viewCount":1858,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876592132,"gmtCreate":1637329442489,"gmtModify":1637329442628,"author":{"id":"4097912578278380","authorId":"4097912578278380","name":"Rosechin","avatar":"https://static.tigerbbs.com/b609bc0ae15909da0a6fbf0d048f7ebd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097912578278380","authorIdStr":"4097912578278380"},"themes":[],"htmlText":"Potential&nbsp;","listText":"Potential&nbsp;","text":"Potential","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/876592132","repostId":"1144455380","repostType":4,"repost":{"id":"1144455380","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637328728,"share":"https://www.laohunote.com/m/news/1144455380?lang=&edition=full","pubTime":"2021-11-19 21:32","market":"us","language":"en","title":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1144455380","media":"Tiger Newspress","summary":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S","content":"<p>Pfizer and BioNTech SE stocks climbed about 2%&nbsp;in premarket trading&nbsp;after&nbsp;they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p>\n<p><img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p>\n<p>Pfizer Inc.&nbsp;and BioNTech SE&nbsp;today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p>\n<p>“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p>\n<p>“Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p>\n<p>In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p>\n<p>A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p>\n<p>Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech SE stocks climbed about 2% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer and BioNTech SE stocks climbed about 2%&nbsp;in premarket trading&nbsp;after&nbsp;they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p>\n<p><img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p>\n<p>Pfizer Inc.&nbsp;and BioNTech SE&nbsp;today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p>\n<p>“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p>\n<p>“Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p>\n<p>In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p>\n<p>A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p>\n<p>Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144455380","content_text":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.\n\nPfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\n“Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”\nIn October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.\nA booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.\nPfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":871708992,"gmtCreate":1637109801542,"gmtModify":1637109856444,"author":{"id":"4097912578278380","authorId":"4097912578278380","name":"Rosechin","avatar":"https://static.tigerbbs.com/b609bc0ae15909da0a6fbf0d048f7ebd","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4097912578278380","authorIdStr":"4097912578278380"},"themes":[],"htmlText":"Good to invest this sharr","listText":"Good to invest this sharr","text":"Good to invest this sharr","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/871708992","repostId":"2183024810","repostType":2,"repost":{"id":"2183024810","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1636978318,"share":"https://www.laohunote.com/m/news/2183024810?lang=&edition=full","pubTime":"2021-11-15 20:11","market":"hk","language":"en","title":"Online Gaming Business Drives Sohu's 37% Revenue Growth In Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2183024810","media":"Benzinga","summary":"\n","content":"<html><body><ul>\n<li><strong>Sohu.com Ltd</strong> (NASDAQ:SOHU) reported third-quarter FY21 revenue growth of 37% year-on-year to $216 million. Revenue improved 6% quarter-over-quarter.</li>\n<li>Brand advertising revenues declined 18% Y/Y to $34 million due to decreases in portal advertising revenues. </li>\n<li>Online game revenues grew 65% Y/Y to $167 million, mainly contributed by TLBB Vintage.</li>\n<li>The gross margin was 74%, expanding 800 basis points Y/Y and contracting 200 basis points sequentially. The gross margin for online games was 83% versus 80% last year and 89% in 2Q21.</li>\n<li>Non-GAAP earnings per ADS were $0.44.</li>\n<li>Sohu held $1.57 billion in cash and equivalents.</li>\n<li>Average monthly active user accounts for Changyou<strong> </strong>PC games increased 3% Y/Y to 2 million, mainly due to the TLBB Vintage. Average MAU for Changyou<strong> </strong>mobile games rose 22% Y/Y to 4.6 million, mainly due to the launch of Little Raccoon: Heroes.</li>\n<li>\"Overall, we delivered better than expected top line and bottom line performance thanks to the solid performance of our online game business,\" Chair and CEO Dr. Charles Zhang said.</li>\n<li><strong>Share buyback:</strong> The board authorized a share repurchase program of up to $100 million of the outstanding ADSs of Sohu over the next twelve months.</li>\n<li><strong>Outlook</strong>: Sohu sees Q4 brand advertising revenue decrease 26%-33% Y/Y to $28 million - $31 million.</li>\n<li>It sees Q4 online game revenues growth 23%-29% to $140 million - $150 million.</li>\n<li><strong>Price Action:</strong> SOHU shares closed higher by 0.09% at $21.57 on Friday.</li>\n</ul>\n</body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Online Gaming Business Drives Sohu's 37% Revenue Growth In Q3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOnline Gaming Business Drives Sohu's 37% Revenue Growth In Q3\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-15 20:11</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><ul>\n<li><strong>Sohu.com Ltd</strong> (NASDAQ:SOHU) reported third-quarter FY21 revenue growth of 37% year-on-year to $216 million. Revenue improved 6% quarter-over-quarter.</li>\n<li>Brand advertising revenues declined 18% Y/Y to $34 million due to decreases in portal advertising revenues. </li>\n<li>Online game revenues grew 65% Y/Y to $167 million, mainly contributed by TLBB Vintage.</li>\n<li>The gross margin was 74%, expanding 800 basis points Y/Y and contracting 200 basis points sequentially. The gross margin for online games was 83% versus 80% last year and 89% in 2Q21.</li>\n<li>Non-GAAP earnings per ADS were $0.44.</li>\n<li>Sohu held $1.57 billion in cash and equivalents.</li>\n<li>Average monthly active user accounts for Changyou<strong> </strong>PC games increased 3% Y/Y to 2 million, mainly due to the TLBB Vintage. Average MAU for Changyou<strong> </strong>mobile games rose 22% Y/Y to 4.6 million, mainly due to the launch of Little Raccoon: Heroes.</li>\n<li>\"Overall, we delivered better than expected top line and bottom line performance thanks to the solid performance of our online game business,\" Chair and CEO Dr. Charles Zhang said.</li>\n<li><strong>Share buyback:</strong> The board authorized a share repurchase program of up to $100 million of the outstanding ADSs of Sohu over the next twelve months.</li>\n<li><strong>Outlook</strong>: Sohu sees Q4 brand advertising revenue decrease 26%-33% Y/Y to $28 million - $31 million.</li>\n<li>It sees Q4 online game revenues growth 23%-29% to $140 million - $150 million.</li>\n<li><strong>Price Action:</strong> SOHU shares closed higher by 0.09% at $21.57 on Friday.</li>\n</ul>\n</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.benzinga.com/news/earnings/21/11/24084879/online-gaming-business-drives-sohus-37-revenue-growth-in-q3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2183024810","content_text":"Sohu.com Ltd (NASDAQ:SOHU) reported third-quarter FY21 revenue growth of 37% year-on-year to $216 million. Revenue improved 6% quarter-over-quarter.\nBrand advertising revenues declined 18% Y/Y to $34 million due to decreases in portal advertising revenues. \nOnline game revenues grew 65% Y/Y to $167 million, mainly contributed by TLBB Vintage.\nThe gross margin was 74%, expanding 800 basis points Y/Y and contracting 200 basis points sequentially. The gross margin for online games was 83% versus 80% last year and 89% in 2Q21.\nNon-GAAP earnings per ADS were $0.44.\nSohu held $1.57 billion in cash and equivalents.\nAverage monthly active user accounts for Changyou PC games increased 3% Y/Y to 2 million, mainly due to the TLBB Vintage. Average MAU for Changyou mobile games rose 22% Y/Y to 4.6 million, mainly due to the launch of Little Raccoon: Heroes.\n\"Overall, we delivered better than expected top line and bottom line performance thanks to the solid performance of our online game business,\" Chair and CEO Dr. Charles Zhang said.\nShare buyback: The board authorized a share repurchase program of up to $100 million of the outstanding ADSs of Sohu over the next twelve months.\nOutlook: Sohu sees Q4 brand advertising revenue decrease 26%-33% Y/Y to $28 million - $31 million.\nIt sees Q4 online game revenues growth 23%-29% to $140 million - $150 million.\nPrice Action: SOHU shares closed higher by 0.09% at $21.57 on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1065,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}